NHS Digital has published its latest annual report of breast cancer screening performance in England, covering the year 1 April 2016 to 31 March 2017. During those 12 months, we invited just under 3 million women for screening and screened 2.2 million, an increase of 1.3% on the previous year.
Jacquie Jenkins has worked in breast screening since 1996 gaining vast experience of the programme working in several senior regional roles within the quality assurance service. She particularly has an interest in data and screening performance and has worked to develop methods to analyse individual performance for dissemination to professionals within the programme.
She is now the national programme manager leading on the operational management of the breast screening programme (NHSBSP). Her first degree in Social Policy and Administration and post-graduate qualifications in research methods are useful in key components of the role which include leading on the revision of Programme Standards and having oversight of projects that contribute to the quality improvement and effective delivery of the Programme.
Jacquie worked in banking and taught classical guitar prior to working in the NHSBSP.
We have published 2 new guidance documents to support mammographers who work in the breast screening programme.
The newly published ‘Breast screening: interval cancers and duty of candour toolkit’ advises health professionals on how to communicate information on interval cancers to women who were previously screened in the programme.
PHE is involved in an initiative to develop an apprenticeship for the new role of ‘associate mammographer’, which we hope will encourage many to enter the profession and address the national shortage of mammographers.
In our quest to provide free, high quality, easy to access training for those informing women about breast screening, we often collaborate with other organisations. This makes sure we can get the right information to as many of you as possible and that you can evidence your learning in line with your professional continuing professional development (CPD).
The NHS Breast Screening Programme has produced new guidance on the reporting, classification and monitoring of interval cancers. These are cancers diagnosed after a screening appointment at which a woman received a normal result and before her next scheduled screening appointment.
We have published the new consolidated standards for the NHS Breast Screening Programme.
In 1988, the UK implemented the first national breast screening programme following evidence published in the Forrest Report.
The NHS Breast Screening Programme screens around 1.2 million women in England each year.
The NHS Breast Screening Programme relies on high quality assessments being carried out when potential abnormalities are found during screening.